John Davis has been appointed to the newly created role of director of discovery at Selcia Ltd. Mr. Davis joins the company from Convergence Pharmaceuticals, where he served as head of biology and was a co-founder of the company.   Mr. Davis’ research has focused on cardiovascular, oncology and CNS disorders. He gained 20 years of drug discovery experience at SmithKline Beecham and GlaxoSmithKline across range of target classes including ion channels, GPCRs, kinases and proteases. He was respons...